Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRheumatology Physician in Newark, DE
NPI: 1114963626Primary Practice Location
Delaware Medical Care Associates LLC
550 Stanton Christiana Rd, Newark, DE
Primary Employer
Javed Rheumatology Associates, Inc
javedrheumatologyassociates.com
HQ Phone
Get M.D. Sheerin's Phone Numberphone_androidMobile
Get M.D. Sheerin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDE State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 144 | 277 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 84 | 105 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 33 | 86 |
| 4 | J7050Infusion, normal saline solution , 250 cc | 27 | 139 |
| 5 | J0897Injection, denosumab, 1 mg | 24 | 2,340 |
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3196165 (Otilimab), DRUG: Tofacitinib 5 mg
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: csDMARDs, BIOLOGICAL: GSK3196165 (Otilimab), BIOLOGICAL: Sarilumab, DRUG: Placebo to GSK3196165/ Sarilumab
Lead Sponsor: R-Pharm International, LLC
Collaborators: IQVIA Pvt. Ltd, OCT Clinical Trials
Intervention / Treatment: DRUG: Concomitant treatment, DRUG: Olokizumab 64 mg SC q4w, DRUG: Olokizumab 64 mg SC q2w
